Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | BRD2 | P25440 | 1/20 | 0.33 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | PLK1 | P53350 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31041096 | 0.81 | CA1 (0.38) | CRBNBRD4BRD2BRD3GBA1 | |
| SCHEMBL31478285 | 0.81 | HDAC4 (0.43) | BRD4BRD2BRD3GBA1HDAC4 | |
| SCHEMBL19451363 | 0.79 | CRBN (0.34) | CRBNSUCNR1 | |
| SCHEMBL29427494 | 0.77 | TDP1 (0.32) | PLK1 | |
| SCHEMBL29427447 | 0.77 | TDP1 (0.32) | PLK1 | |
| SCHEMBL31328769 | 0.77 | CRBN (0.33) | CRBNSUCNR1 | |
| SCHEMBL17284191 | 0.74 | CA12 (0.36) | CRBN | |
| SCHEMBL17722876 | 0.71 | CRBN (0.38) | CRBNKDM4E | |
| SCHEMBL22109240 | 0.71 | KDM4E (0.44) | HDAC4HDAC6KDM4EGLAL3MBTL1 | |
| SCHEMBL20904591 | 0.71 | PLK1 (0.38) | CRBNPLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025083069-A1 | HER2-BINDING MOLECULES | Hummingbird Bioscience Pte. Ltd. (SG) | 2025-04-24 | — | — | WO | disclosed |